Skip to Content

Clenpiq (citric acid / magnesium oxide / sodium picosulfate) and Alcohol / Food Interactions

There is 1 alcohol/food/lifestyle interaction with Clenpiq (citric acid / magnesium oxide / sodium picosulfate):

Moderate

sodium picosulfate ↔ food

Moderate Food Interaction

Consumer information for this interaction is not currently available.

ADJUST DOSING INTERVAL: Bowel cleansing products can increase the gastrointestinal transit rate. Oral medications administered within one hour of the start of administration of the bowel cleansing solution may be flushed from the gastrointestinal tract and not properly absorbed.

MANAGEMENT: Patients should be advised that absorption of oral medications may be impaired during bowel cleansing treatment. Oral medications (e.g., anticonvulsants, oral contraceptives, antidiabetic agents, antibiotics) should not be administered during and within one hour of starting bowel cleansing treatment whenever possible. However, if concomitant use cannot be avoided, monitoring for reduced therapeutic effects may be advisable.

References

  1. "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc, Tarrytown, NY.
  2. "Product Information. Golytely (polyethylene glycol electrolyte solution)." Braintree, Braintree, MA.

Clenpiq (citric acid / magnesium oxide / sodium picosulfate) drug interactions

There are 597 drug interactions with Clenpiq (citric acid / magnesium oxide / sodium picosulfate)

Clenpiq (citric acid / magnesium oxide / sodium picosulfate) disease interactions

There are 2 disease interactions with Clenpiq (citric acid / magnesium oxide / sodium picosulfate) which include:

More about Clenpiq (citric acid / magnesium oxide / sodium picosulfate)

Related treatment guides

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide